Jasbir Seehra - 04 Apr 2025 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
04 Apr 2025
Transactions value $
$14,810
Form type
4
Filing time
07 Apr 2025, 16:15:07 UTC
Previous filing
23 Feb 2024
Next filing
05 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Options Exercise $14,810 +49,367 +19.52% $0.3 302,223 04 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KROS Employee Stock Option (right to buy) Options Exercise $0 -49,367 -16.36% $0 252,444 04 Apr 2025 Common Stock 49,367 $0.3 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.